Zhaohua Xiao

Jinan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression.

Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression.

Journal: Virulence

Published: August 16, 2025

Deciphering metastasis in pediatric Wilms' and rhabdoid tumors: IMPA2 as a key molecular player and promising therapeutic target.

Deciphering metastasis in pediatric Wilms' and rhabdoid tumors: IMPA2 as a key molecular player and promising therapeutic target.

Journal: Biochemical and biophysical research communications

Published: August 08, 2025

Corrigendum to "A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer" [Biomed. Pharmacother. 184 (2025) 117899].

Corrigendum to "A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer" [Biomed. Pharmacother. 184 (2025) 117899].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 14, 2025

A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer.

A novel missense mutation Smad4 V354L enhances the efficacy of docetaxel in non-small cell lung cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: October 08, 2024

miR-493-5p Silenced by DNA Methylation Promotes Angiogenesis via Exosomes and VEGF-A-Mediated Intracellular Cross-Talk Between ESCC Cells and HUVECs.

miR-493-5p Silenced by DNA Methylation Promotes Angiogenesis via Exosomes and VEGF-A-Mediated Intracellular Cross-Talk Between ESCC Cells and HUVECs.

Journal: International journal of nanomedicine

Published: February 19, 2024

Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.

Circ_16601 facilitates Hippo pathway signaling via the miR-5580-5p/FGB axis to promote my-CAF recruitment in the TME and LUAD progression.

Journal: Respiratory research

Published: June 14, 2023

Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA.

Circular RNA circ-FIRRE interacts with HNRNPC to promote esophageal squamous cell carcinoma progression by stabilizing GLI2 mRNA.

Journal: Cancer science

Published: February 05, 2023

CircABCA13 acts as a miR-4429 sponge to facilitate esophageal squamous cell carcinoma development by stabilizing SRXN1.

CircABCA13 acts as a miR-4429 sponge to facilitate esophageal squamous cell carcinoma development by stabilizing SRXN1.

Journal: Cancer science

Published: January 05, 2023

Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.

Exosomal miR-10527-5p Inhibits Migration, Invasion, Lymphangiogenesis and Lymphatic Metastasis by Affecting Wnt/β-Catenin Signaling via Rab10 in Esophageal Squamous Cell Carcinoma.

Journal: International journal of nanomedicine

Published: September 27, 2022

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP.

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP.

Journal: Cell death & disease

Published: July 08, 2022

Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma.

Triptolide inhibits epithelial-mesenchymal transition phenotype through the p70S6k/GSK3/β-catenin signaling pathway in taxol-resistant human lung adenocarcinoma.

Journal: Translational lung cancer research

Published: March 15, 2021

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial‑mesenchymal transition through TGF‑β/Smad signaling.

Journal: Oncology reports

Published: July 22, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026